{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:46:29Z","timestamp":1792071989053,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2002,7,31]],"date-time":"2002-07-31T00:00:00Z","timestamp":1028073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,7,31]],"date-time":"2002-07-31T00:00:00Z","timestamp":1028073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2002,8,1]]},"DOI":"10.1038\/sj.leu.2402584","type":"journal-article","created":{"date-parts":[[2002,10,21]],"date-time":"2002-10-21T10:59:36Z","timestamp":1035197976000},"page":"1460-1469","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation"],"prefix":"10.1038","volume":"16","author":[{"given":"ML","family":"S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Vidriales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MC","family":"L\u00f3pez-Berges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MA","family":"Garc\u00eda-Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MJ","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MJ","family":"Calmuntia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JF","family":"San Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Orfao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,7,31]]},"reference":[{"key":"BF2402584_CR1","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1182\/blood.V98.6.1746","volume":"98","author":"JF San Miguel","year":"2001","unstructured":"San Miguel JF, Vidriales MB, L\u00f3pez-Berges C, D\u00edaz-Mediavilla J, Guti\u00e9rrez N, Ca\u00f1izo C, Ramos F, Calmuntia MJ, P\u00e9rez JJ, Gonz\u00e1lez M, Orfao A . Early immunophenotypical evaluation of minimal residual disease (MRD) in AML identifies different patient risk-groups and may contribute to post-induction treatment stratification Blood 2001 98: 1746\u20131751","journal-title":"Blood"},{"key":"BF2402584_CR2","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1200\/JCO.1998.16.12.3774","volume":"16","author":"J Ciudad","year":"1998","unstructured":"Ciudad J, San Miguel JF, L\u00f3pez-Berges MC, Vidriales B, Valverde B, Ocqueteau M, Mateos G, Caballero MD, Hern\u00e1ndez J, Moro MJ, Mateos MV, Orfao A . Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia J Clin Oncol 1998 16: 3774\u20133781","journal-title":"J Clin Oncol"},{"key":"BF2402584_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/sj.leu.2401279","volume":"13","author":"P Lucio","year":"1999","unstructured":"Lucio P, Parreira A, Van den Beemd MW, Van Lochem EG, Van Wering ER, Baars E, Porwit-MacDonald A, Bjorklund E, Gaipa G, Biondi A, Orfao A, Janossy G, Van Dongen JJ, San Miguel JF . Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL Leukemia 1999 13: 419\u2013427","journal-title":"Leukemia"},{"key":"BF2402584_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJM199808273390904","volume":"339","author":"H Cave","year":"1998","unstructured":"Cave H, Van der Werff J, Bosch T, Suciu S, Guidal C, Waterkeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, Vilmer E . Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia N Engl J Med 1998 339: 591\u2013598","journal-title":"N Engl J Med"},{"key":"BF2402584_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","volume":"351","author":"E Coustan-Smith","year":"1998","unstructured":"Coustan-Smith E, Behm FG, Sanchez J, Boyett JM, Hancock ML, Raimondi SC, Rubnitz JE, Rivera GK, Sandlund JT, Pui CH, Campana D . Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia Lancet 1998 351: 550\u2013554","journal-title":"Lancet"},{"key":"BF2402584_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1040-8428(99)00032-3","volume":"32","author":"JF San Miguel","year":"1999","unstructured":"San Miguel JF, Ciudad J, Vidriales MB, Orfao A, Lucio P, Porwith-MacDonald A, Gaipa G, Van Wering E, Van Dongen JJ . Immunophenotypical detection of minimal residual disease in acute leukemia Crit Rev Oncol Hematol 1999 32: 175\u2013185","journal-title":"Crit Rev Oncol Hematol"},{"key":"BF2402584_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/BF01700374","volume":"70","author":"A Macedo","year":"1995","unstructured":"Macedo A, Orfao A, Vidriales MB, L\u00f3pez-Berges C, Valverde B, Gonz\u00e1lez M, Caballero MD, Ramos F, Mart\u00ednez M, Fern\u00e1ndez-Calvo J . Characterization of aberrant phenotypes in acute myeloblastic leukemia Ann Hematol 1995 70: 189\u2013194","journal-title":"Ann Hematol"},{"key":"BF2402584_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1365-2141.1999.01685.x","volume":"107","author":"J Almeida","year":"1999","unstructured":"Almeida J, Orfao A, Ocqueteau M, Mateo G, Corral M, Caballero MD, Blade J, Moro MJ, Hern\u00e1ndez J, San Miguel JF . High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma Br J Haematol 1999 107: 121\u2013131","journal-title":"Br J Haematol"},{"key":"BF2402584_CR9","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.V90.6.2465","volume":"90","author":"JF San Miguel","year":"1997","unstructured":"San Miguel JF, Martinez A, Macedo A, Vidriales MB, L\u00f3pez-Berges C, Gonz\u00e1lez M, Caballero D, Garc\u00eda-Marcos MA, Ramos F, Fern\u00e1ndez-Calvo J, Calmuntia MJ, D\u00edaz-Mediavilla J, Orfao A . Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients Blood 1997 90: 2465\u20132470","journal-title":"Blood"},{"key":"BF2402584_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/10428199409052682","volume":"13 (Suppl. 1)","author":"A Orfao","year":"1994","unstructured":"Orfao A, Ciudad J, Lopez-Berges MC, L\u00f3pez A, Vidriales B, Caballero MD, Valverde B, Gonz\u00e1lez M, San Miguel JF . Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry Leuk Lymphoma 1994 13 (Suppl. 1): 87\u201390","journal-title":"Leuk Lymphoma"},{"key":"BF2402584_CR11","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1056\/NEJM200012143432402","volume":"343","author":"KR Rai","year":"2000","unstructured":"Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD, Schiffer CA . Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia N Engl J Med 2000 343: 1750\u20131757","journal-title":"N Engl J Med"},{"key":"BF2402584_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00001622-199703000-00002","volume":"9","author":"JG Gribben","year":"1997","unstructured":"Gribben JG . Bone marrow transplantation for low-grade B cell malignancies Curr Opin Oncol 1997 9: 117\u2013121","journal-title":"Curr Opin Oncol"},{"key":"BF2402584_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00282-000-0031-2","volume":"42","author":"E Montserrat","year":"2000","unstructured":"Montserrat E . Current therapy for CLL Hematol Cell Ther 2000 42: 31\u201333","journal-title":"Hematol Cell Ther"},{"key":"BF2402584_CR14","first-page":"198","volume":"36","author":"B Coiffier","year":"1999","unstructured":"Coiffier B, Thieblemont C, Felman P, Salles G, Berger F . Indolent nonfollicular lymphomas: characteristics, treatment and outcome Semin Hematol 1999 36: 198\u2013208","journal-title":"Semin Hematol"},{"key":"BF2402584_CR15","first-page":"209","volume":"36","author":"VA Boussiotis","year":"1999","unstructured":"Boussiotis VA, Freedman AS, Nadler LM . Bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia Semin Hematol 1999 36: 209\u2013216","journal-title":"Semin Hematol"},{"key":"BF2402584_CR16","first-page":"155","volume":"36","author":"MS Tallman","year":"1999","unstructured":"Tallman MS, Peterson LC, Hakimian D, Gillis S, Polliack A . Treatment of hairy-cell leukemia: current views Semin Hematol 1999 36: 155\u2013163","journal-title":"Semin Hematol"},{"key":"BF2402584_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1365-2141.2000.01900.x","volume":"108","author":"M Michallet","year":"2000","unstructured":"Michallet M, Thiebaut A, Dreger P, Remes K, Milpied N, Santini G, Hamon M, Bjorkstrand B, Kimby E, Belhabri A, Tanguy ML, Apperley JF . Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP) Br J Haematol 2000 108: 595\u2013601","journal-title":"Br J Haematol"},{"key":"BF2402584_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1023\/A:1026481430446","volume":"10","author":"CM Wendtner","year":"1999","unstructured":"Wendtner CM, Schmitt B, Wilhelm M, Dreger P, Montserrat E, Emmerich B, Hallek M . Redefining the therapeutic goals in chronic lymphocytic leukemia: towards an evidence-based, risk-adapted therapy Ann Oncol 1999 10: 505\u2013509","journal-title":"Ann Oncol"},{"key":"BF2402584_CR19","first-page":"1665","volume":"5","author":"MS Tallman","year":"1999","unstructured":"Tallman MS, Hakimian D, Kopecky KJ, Wheaton S, Wollins E, Foucar K, Cassileth PA, Habermann T, Grever M, Rowe JM, Peterson LC . Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxicoformycin and prediction of early relapse Clin Cancer Res 1999 5: 1665\u20131670","journal-title":"Clin Cancer Res"},{"key":"BF2402584_CR20","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/sj.leu.2401892","volume":"14","author":"MA Weiss","year":"2000","unstructured":"Weiss MA, Glenn M, Maslak P, Rahman Z, Noy A, Zelenetz A, Seheinberg DA, Golde DW . Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy Leukemia 2000 14: 1577\u20131582","journal-title":"Leukemia"},{"key":"BF2402584_CR21","first-page":"27","volume":"4 (Suppl. 2)","author":"BD Cheson","year":"1998","unstructured":"Cheson BD . New prospects in the treatment of indolent lymphomas with purine analogues Cancer J Sci Am 1998 4 (Suppl. 2): 27\u201336","journal-title":"Cancer J Sci Am"},{"key":"BF2402584_CR22","first-page":"275","volume":"7","author":"M Michallet","year":"1991","unstructured":"Michallet M, Corront B, Hollard D, Gratwohl A, Milpied N, Dauriac C, Brunet S, Soler J, Jouet JP, Esperou Bourdeau H . Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: 17 cases. Report from the EBMTG Bone Marrow Transplant 1991 7: 275\u2013279","journal-title":"Bone Marrow Transplant"},{"key":"BF2402584_CR23","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1634\/theoncologist.5-5-376","volume":"5","author":"JD Hainsworth","year":"2000","unstructured":"Hainsworth JD . Monoclonal antibody therapy in lymphoid malignancies Oncologist 2000 5: 376\u2013384","journal-title":"Oncologist"},{"key":"BF2402584_CR24","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1023\/A:1008474526373","volume":"9","author":"ZS Pavletic","year":"1998","unstructured":"Pavletic ZS, Bierman PJ, Vose JM, Bishop MR, Wu CD, Pierson JL, Kollath JP, Weisenburger DD, Kessinger A, Armitage JO . High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma Ann Oncol 1998 9: 1023\u20131026","journal-title":"Ann Oncol"},{"key":"BF2402584_CR25","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1038\/sj.leu.2400835","volume":"11","author":"E Cabezudo","year":"1997","unstructured":"Cabezudo E, Matutes E, Ramrattan M, Morilla R, Catovsky D . Analysis of residual disease in chronic lymphocytic leukemia by flow cytometry Leukemia 1997 11: 1909\u20131914","journal-title":"Leukemia"},{"key":"BF2402584_CR26","first-page":"1019","volume":"8","author":"B Lenormand","year":"1994","unstructured":"Lenormand B, Bizet M, Fruchart C, Tilly H, Daliphard S, Thouret F, Canipel C, Callat MP, Piguet H, Lefranc MP . Residual disease in B-cell chronic lymphocytic leukemia patients and prognostic value Leukemia 1994 8: 1019\u20131026","journal-title":"Leukemia"},{"key":"BF2402584_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1182\/blood.V98.1.29","volume":"98","author":"AC Rawstron","year":"2001","unstructured":"Rawstron AC, Kennedy B, Evans PA, Davies FE, Richards SJ, Haynes AP, Russell NH, Hale G, Morgan GJ, Jack AS, Hillmen P . Quantitation of minimal residual disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy Blood 2001 98: 29\u201335","journal-title":"Blood"},{"key":"BF2402584_CR28","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"N Harris","year":"1999","unstructured":"Harris N, Jaffe E, Diebold J, Flandrin G, Muller-Hermelink H, Vardiman J, Lister T, Bloomfield C . World Health Organization classification of neoplastic diseases of the hematomoietic and lymphoid tissues: report of the Clinical Advisory Comittee Meeting \u2013 Airlie House, Virginia, November 1997 J Clin Oncol 1999 17: 3835\u20133849","journal-title":"J Clin Oncol"},{"key":"BF2402584_CR29","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wols-Peeters C, Falini B, Gatter KC, Grogan TM, Isacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA . A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 1994 84: 1361\u20131392","journal-title":"Blood"},{"key":"BF2402584_CR30","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1038\/sj.leu.2401511","volume":"13","author":"JA Garc\u00eda-Vela","year":"1999","unstructured":"Garc\u00eda-Vela JA, Delgado I, Benito L, Monteserin MC, Garc\u00eda-Alonso L, Somolinos N, Andreu MA, O\u00f1a F . CD79b expression in B-cell chronic lymphocytic leukemia: its implication for minimal residual disease detection Leukemia 1999 13: 1501\u20131505","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402584.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402584","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402584.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:35:02Z","timestamp":1648762502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,31]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8,1]]}},"alternative-id":["BF2402584"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402584","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,31]]},"assertion":[{"value":"15 November 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}